|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Product | |||||
| Service | |||||
| Total revenue | |||||
| Cost of revenue | |||||
| Product | |||||
| Service | |||||
| Total cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Goodwill impairment | |||||
| Lease termination expense, net | |||||
| Legal settlement expense, net of insurance proceeds | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest expense, net | |||||
| Dividend and interest income | |||||
| Dividend income | |||||
| Gain (loss) on marketable securities, net | |||||
| Interest income | |||||
| Unrealized gain on trading securities | |||||
| Realized loss on trading securities | |||||
| Change in fair value of warrant liabilities | |||||
| Other income (expense), net | |||||
| Loss before provision for income taxes | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Basic net loss per share (in dollars per share) | |||||
| Diluted net loss per share (in dollars per share) | |||||
| Weighted-average shares used to compute net loss per share attributable to common stockholders, basic (in shares) | |||||
| Weighted-average shares used to compute net loss per share attributable to common stockholders, diluted (in shares) | |||||
| Other comprehensive gain (loss): | |||||
| Net unrealized (loss) gain on marketable securities, net of tax | |||||
| Foreign currency translation adjustment | |||||
| Total other comprehensive (loss) gain, net of tax | |||||
| Comprehensive loss | |||||
Loading...